Description: Due to the increased prevalence of penicillin-resistant bacteria in the treatment of staphylococcal infection in 1961 were introduced into clinical practice one of the semi-synthetic drugs resistant to penicillinase which calls methicillin. However immediately after this event has been reported it’s tolerance [1,2,3].
Methicillin-resistant staphylococcus (MRSA/MTSA) has been widely reported in the world and since the 1980s is now considered a highly contagious infection. MTSA infection and mortality rates are twice as high as methicillin-sensitive staphylococcal aureus infections and it caused to increase hospital bed costs [4,5]. Materials and methodology: The study included a sample of all samples submitted to the NCD for bacteriological analysis in 2018, 2019 and 2020.
Bacteriological specimens were obtained from swabs, wounds, urine, and throat swabs to identify and physically identify methicillin-resistant staphylococcus aureus. The research objectives were obtained from the NCD journal including all investigations from January 1 2018 to December 31, 2020 using the Descriptive Research Method. Results: In 2018, a total of 6419 bacteriological tests were performed with the growth of 4693 bacteria, in 2019 out of 7281 bacteriological tests were performed with the growth of 5485 bacteria, and in 2020 out of 8275 bacteriological tests were performed with the growth of 6894 bacteria.
The MTSA positeve tests accounted 269 (4.1%) bacteriological tests in 2018, in 2019 412 (5.6%) and in 2020 were, 781 (9.4%) from total bacteriological tests fot these years. Conclution The need for bacteriological testing is increasing year by year, which indicates an increase in bacterial infections. Also increased cases of MTSA are reported in the NCD during 2018-2020. The MTSA infections are more common in swabs and pustules.